Supply of a Medicinal Product (Carboplatin) for an Outpatient Oncology Care Center for 2025

RussiaTenders notice for Supply of a Medicinal Product (Carboplatin) for an Outpatient Oncology Care Center for 2025. The reference ID of the tender is 112186037 and it is closing on 23 Dec 2024.

100% Secure Payments

Tender Details

  • Country: Russia
  • Summary: Supply of a Medicinal Product (Carboplatin) for an Outpatient Oncology Care Center for 2025
  • RUT Ref No: 112186037
  • Deadline: 23 Dec 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 324216.00
  • Notice Type: Tender
  • Document Ref. No.: 0319200065724000668
  • Purchaser's Detail :
  • Purchaser : TERRITORY STATE BUDGETARY HEALTH INSTITUTION "NAZAROVSKAYA CENTRAL DISTRICT HOSPITAL
    Russian Federation, 662200, Krasnoyarsk region, Nazarovo city, st. 30 YEARS OF THE VLKSM, D. 94
    Full name:- Litvinov R.A.
    Contact phone number:- 7-39155-72262
    Fax:- No information
    Email :nazrb24@yandex.ru

  • Description :
  • Supply of a medicinal product (CARBOPLATIN) for an outpatient oncology care center for 2025
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us